NEWS and OPINIONS
The Innovation Ecosystem of Winston-Salem’s RegenMed Hub
by Innovation Quarter From developing the world’s first lab-grown organ (a bladder) to the body-on-a-chip platform used for drug toxicity testing and personalized medicine, Winston-Salem-based scientists have been integral to cutting-edge regenerative medicine...
Gene therapy could help restore vision lost to degenerative disease
By Michael Irving - News Atlas Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that convert dormant cells into new...
Stem Cell Therapy Improves Walking in More Advanced Progressive MS
by Physician's Weekly Mesenchymal stem cell-neural progenitor therapy (MSC-NPs) are bone marrow-derived cells with trophic and immunomodulatory properties. Their therapeutic potential in MS was evaluated in a randomized, double-blind, placebo-controlled phase 2 trial....
CRISPR and Single-cell Sequencing Pinpoint Causal Genetic Variants for Traits and Diseases
STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...
Breakthrough research could bring stem cell therapy to the masses
by Justin Jackson - Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor. In...
Longeveron Announces New Long-Term Survival Data from ELPIS I Trial of Lomecel-B™ for Hypoplastic Left Heart Syndrome
By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new long-term follow-up data from the...
From Private Astronaut Missions to In-Space Biomanufacturing: Axiom Space’s Bold Vision
by Innovation Quarter Some things are worth traveling for. We drive the extra hour to one-of-a-kind restaurants, we cross state lines for best-in-class specialists and we travel days to experience unrivaled natural wonders. One day, there will be products that we have...
Early Bird Ends May 8 for Registrations for WSCS 23 June5-9
Combined WSCS & RME Course in Winston-Salem, NC June 5-9EARLY BIRD DISCOUNT WILL END MAY 8 WSCS will be a LIVE IN-PERSON MEETING combined with the WFIRM/RMF Regenerative Medicine Essentials Course in Winston-Salem, NC. The annual World Stem Cell Summit is the...
Stay cool: the longevity tech that “shows insane promise
Aubrey de Grey explains why the time is right to be extremely ambitious and audacious when it comes to longevity research. By Eleanor Garth - Longevity.Technology August will see the second annual Longevity Summit take place in Dublin. Packed with keynote...
Ax-2 Mission to Expand Microgravity Research to Combat Human Disease
By Axiom Space First time bioprinted solid tissue constructs to be sent to the International Space Station and induced pluripotent stem cells to be manufactured in space. Microgravity allows researchers to study the behavior of cells and tissues in a unique...
Regenerative Medicine: A New Path for ALS Treatment
by Cassie Tomlin - Cedars Sinai A first-of-its-kind stem cell therapy for ALS passes a critical safety benchmark, advancing the search to slow down, reverse and prevent the disease. In a parallel study, investigators are growing patient-derived stem cells to model...
Early Bird Registration Extended to May 8!
Combined WSCS & RME Course in Winston-Salem, NC June 5-9 WSCS will be a LIVE IN-PERSON MEETING combined with the WFIRM/RMF Regenerative Medicine Essentials Course in Winston-Salem, NC. The annual World Stem Cell Summit is the LEGACY, interdisciplinary,...